Contact
Please use this form to send email to PR contact of this press release:
Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219
TO:
Please use this form to send email to PR contact of this press release:
Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219
TO: